Scientists designed and tested fluorescent molecules called “FibrilPaint” that bind exclusively to the long, thread-like ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

ST. LOUIS — The Alzheimer’s Association reports that for the first time, more than 7.2 million Americans aged 65 and older are estimated to be living with Alzheimer’s disease in 2025 — a number ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

Recognizing the early signs of Alzheimer’s can feel like standing at the edge of an emotional cliff — overwhelming, terrifying and confusing all at once. But knowing how to respond to early ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...

"ViewMind Atlas is helping us to predict Alzheimer’s dementia in people years before it becomes symptomatic. Doctors will ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...